Ascomycins: Promising agents for the treatment of inflammatory skin diseases

Expert Opinion on Investigational Drugs

Volumn 9, Issue 1, 2000, Pages 69-77

  Paul, C ^a   Graeber, M ^a   Stuetz, A ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Anti inflammatory agents; Ascomycins; Atopic dermatitis; Contact dermatitis; Psoriasis; SDZ ASM 981; Topical

Indexed keywords

ASCOMYCIN; CLOBETASOL PROPIONATE; CORTICOSTEROID; CYCLOSPORIN A; CYTOKINE; DIFLUCORTOLONE VALERATE; PIMECROLIMUS; SDZ 281 240; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ATOPIC DERMATITIS; CLINICAL TRIAL; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; HUMAN; NONHUMAN; PSORIASIS; REVIEW; SKIN ALLERGY; SKIN ATROPHY; SKIN INFLAMMATION;

EID: 0033987120     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.9.1.69     Document Type: Review

References (41)